SG293 represents a differentiated in vivo CAR T cell approach designed to work without lymphodepletion to deliver potent therapeutic activity and exceptional specificity to minimize off-target effects ...
Interim results from SIDNEY Phase 2 trial show EO2463 rapidly induced extensive in vivo expansion of B cell target-specific CD8 ...
Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and ...
Data from pivotal Phase 3 frontMIND trial evaluating tafasitamab (Monjuvi®/Minjuvi®) in first-line diffuse large b-cell lymphoma (DLBCL) selected for prestigious Plenary Abstracts SessionOral and ...
First-ever FDA approved PROTAC supports the further development and potential of Arvinas' pipeline - - Announced FDA Approval of VEPPANU (vepdegestrant) for the treatment of ESR1m, ER+/HER2- advanced ...
LUND, SE / ACCESS Newswire / May 12, 2026 / BioInvent International (STO:BINV) - BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a leader in the discovery of novel immune-modulatory ...
A growing body of scientific research is intensifying scrutiny of atrazine, one of the most commonly used herbicides in ...
Cap Biopharma Stocks that Could See Big Growth in 2023 Arvinas (NASDAQ:ARVN) said its first quarter was marked by the FDA ...
CardioPharma, Inc., a specialty pharmaceutical company focused on combinatorial drug development for cardiovascular disease, is currently reviewing applications for secondary analyses of existing ...
Arvinas and Pfizer to receive $85 million in upfront and transition payments with potential for additional $320 million in development, regulatory, and commercial milestones and tiered royalites on ...
NEW YORK – Curocell and ProBio, which provides cell therapy manufacturing support to biotechs, say they're one step closer to treating lymphoma patients in South Korea with the autologous ...
Immunosenescence is the age-related decline and remodeling of the immune system, profoundly influencing susceptibility to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results